基于聚合物的水分散性和生物相容性有机上转化纳米颗粒用于通过皮肤输送.
Hye Eun Choi1, Jeong-Min Park2, Woo Yeup Jeong1
1School of Chemical Engineering and Institute for Advanced Organic Materials, Pusan National University, Busan 46241, Republic of Korea.
Biomaterials research
|November 20, 2024
概括
研究人员开发了新的纳米粒子,将红光转化为蓝光,增强深层组织透,用于像素成像和药物输送等先进的光医学应用.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 照相医疗 (photomedicine) 是一种医学.
背景情况:
- 光医学面临的挑战是光线穿透到组织的深度.
- 现有的基于胺的上转换 (UC) 系统需要高激光功率,效率低.
- 有机三倍-三倍灭绝上转换 (TTA-UC) 提供了一个有前途的替代方案,具有高量子产量和低激发功率.
研究的目的:
- 开发一种新的,水分散的纳米粒子系统,用于增强光医学.
- 使用TTA-UC将红光转换为蓝光,以深入组织透.
- 创建一个平台,用于非侵入性皮肤透射输送和先进的治疗应用.
主要方法:
- 合成的氨酸 (HA) 结合聚烯酸 (PCL) 纳米颗粒装载TTA-UC染色体 (HA-PCL/UC NPs).
- 评估了纳米粒子分散性,量子产量,HeLa细胞中的细胞成像能力,以及猪皮肤中的组织透.
- 证明了红光到蓝光的转换 (635nm到470nm).
主要成果:
- 在蒸水中,HA-PCL/UC NPs的量子产量高达1.6%.
- 在使用开发的纳米粒子的HeLa细胞中观察到改善的细胞成像.
- 在猪皮肤中证明了有效的深层组织透和向上转换的蓝光发射.
结论:
- 开发的HA-PCL/UC NP为克服光医学中的光透限制提供了一个有希望的解决方案.
- 这种TTA-UC纳米粒子系统可以有效地将红光转化为蓝光,用于非侵入性透皮应用.
- 该平台具有下一代生物成像,光动力疗法和向药物输送的巨大潜力.
相关概念视频
01:27Bioavailability Enhancement: Drug Permeability Enhancement
352
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
352
01:30Modified-Release Drug Delivery Systems: Stimuli-Activated
177
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
177
01:24Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
01:18Transdermal Drug Delivery Systems
233
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
233